İlhan Öztop

2.0k total citations
106 papers, 1.4k citations indexed

About

İlhan Öztop is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, İlhan Öztop has authored 106 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in İlhan Öztop's work include Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). İlhan Öztop is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). İlhan Öztop collaborates with scholars based in Türkiye, United States and Iceland. İlhan Öztop's co-authors include Ahmet Alacacıoğlu, Uğur Yılmaz, Tuğba Yavuzşen, Arzu Yaren, Hülya Ellıdokuz, Cem Terzi, Aras Emre Canda, Özgül Sağol, Mehmet Füzün and Selman Sökmen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

İlhan Öztop

100 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlhan Öztop Türkiye 23 766 309 303 175 175 106 1.4k
Catherine G. Lam United States 24 445 0.6× 157 0.5× 363 1.2× 224 1.3× 139 0.8× 66 2.1k
Ahmet Alacacıoğlu Türkiye 25 948 1.2× 254 0.8× 369 1.2× 264 1.5× 82 0.5× 159 2.0k
Florian Scotté France 27 1.1k 1.4× 395 1.3× 459 1.5× 298 1.7× 116 0.7× 131 2.0k
Chan Shen United States 17 654 0.9× 170 0.6× 272 0.9× 104 0.6× 56 0.3× 50 1.4k
John Leighton United States 16 785 1.0× 166 0.5× 440 1.5× 269 1.5× 84 0.5× 37 1.3k
Aram N. Demirjian United States 13 277 0.4× 480 1.6× 297 1.0× 225 1.3× 120 0.7× 26 1.1k
Michael O. Meyers United States 24 708 0.9× 555 1.8× 312 1.0× 238 1.4× 70 0.4× 81 1.5k
Yi‐Ching Hsieh United States 17 450 0.6× 269 0.9× 373 1.2× 103 0.6× 50 0.3× 21 1.4k
Giampaolo Ugolini Italy 21 427 0.6× 337 1.1× 201 0.7× 141 0.8× 220 1.3× 81 1.2k
Sheetal Kircher United States 22 972 1.3× 199 0.6× 210 0.7× 137 0.8× 53 0.3× 108 1.8k

Countries citing papers authored by İlhan Öztop

Since Specialization
Citations

This map shows the geographic impact of İlhan Öztop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlhan Öztop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlhan Öztop more than expected).

Fields of papers citing papers by İlhan Öztop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlhan Öztop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlhan Öztop. The network helps show where İlhan Öztop may publish in the future.

Co-authorship network of co-authors of İlhan Öztop

This figure shows the co-authorship network connecting the top 25 collaborators of İlhan Öztop. A scholar is included among the top collaborators of İlhan Öztop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlhan Öztop. İlhan Öztop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öztop, İlhan, et al.. (2023). The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma. Journal of Clinical Medicine. 12(17). 5434–5434. 14 indexed citations
2.
Öztop, İlhan, Yasemin Başbınar, Tarkan Ünek, et al.. (2023). The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer. The Turkish Journal of Gastroenterology. 34(3). 278–286. 1 indexed citations
3.
Karadibak, Didem, et al.. (2023). Predictors of the 6-min walk test in patients with ovarian cancer. Supportive Care in Cancer. 31(4). 248–248. 2 indexed citations
4.
Uğur, Özlem, et al.. (2022). Symptom clusters in patients with lung cancer patients receiving chemotherapy. SHILAP Revista de lepidopterología. 8(1). 17–26. 1 indexed citations
5.
Terzi, Cem, Naci̇ye Çiğdem Arslan, Ersin Öztürk, et al.. (2019). Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. Colorectal Disease. 22(3). 279–288. 33 indexed citations
6.
Salman, Tarık, Umut Varol, Utku Oflazoğlu, et al.. (2016). Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. Chemotherapy. 61(6). 281–286. 46 indexed citations
7.
Obuz, Funda, Ahmet Çelik, Selman Sökmen, et al.. (2014). Diffusion-weighted MRI and MR- volumetry - in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magnetic Resonance Imaging. 33(2). 201–212. 45 indexed citations
8.
Akman, Tülay, İlhan Öztop, Doğan Koca, et al.. (2014). Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience. Chemotherapy. 60(4). 228–238. 5 indexed citations
9.
Erşen, Ayça, Tülay Akman, Özgül Sağol, et al.. (2014). Tumor deposits in gastric carcinomas. Pathology - Research and Practice. 210(9). 565–570. 24 indexed citations
10.
Ünal, Olçun Ümit, İlhan Öztop, Ozan Yazıcı, et al.. (2014). Treatment and Prognostic Factors in Primary Peritoneal Carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO). Oncology Research and Treatment. 37(6). 332–338. 7 indexed citations
11.
Baskın, Yasemin, Gizem Calibasi‐Kocal, Aras Emre Canda, et al.. (2014). KRAS and BRAF mutation frequencies in a series of Turkish colorectal cancer patients. Translational Cancer Research. 3(2). 160–166. 11 indexed citations
12.
Koca, Doğan, et al.. (2012). The factors that have an impact on the development of brain metastasis in the patients with breast cancer. Journal of Cancer Research and Therapeutics. 8(4). 542–542. 6 indexed citations
13.
Turan, Nedim, Mustafa Beneklı, Doğan Koca, et al.. (2012). Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer. Oncology. 84(1). 14–21. 18 indexed citations
14.
Koca, Doğan, et al.. (2011). Clinical and Electrocardiography Changes in Patients Treated with Capecitabine. Chemotherapy. 57(5). 381–387. 38 indexed citations
15.
Alacacıoğlu, Ahmet, Işıl Somali, Hilal Sipahi, et al.. (2009). Complementary-alternative medicine among cancer patients in the western region of Turkey.. PubMed. 14(2). 265–9. 33 indexed citations
16.
Önen, Ahmet, Kemal Yücesoy, Sami Karapolat, et al.. (2007). [Surgical treatment in non-small cell lung cancer invading to the chest wall (T3) and vertebra (T4)].. PubMed. 55(4). 383–9. 4 indexed citations
17.
Yaren, Arzu & İlhan Öztop. (2007). Küçük Hücreli Dışı Akciğer Kanserinde Prognoztik Faktörler. Turkiye Klinikleri Tip Bilimleri Dergisi. 27(1). 72–78. 1 indexed citations
18.
Yaren, Arzu & İlhan Öztop. (2006). Erken Evre Küçük Hücreli Dışı Akciğer Kanserinde Adjuvan Kemoterapi. Turkiye Klinikleri Tip Bilimleri Dergisi. 26(6). 649–654. 1 indexed citations
19.
Yaren, Arzu, İlhan Öztop, Eksal Kargı, et al.. (2006). Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. International Journal of Clinical Practice. 60(6). 675–682. 30 indexed citations
20.
Saydam, Nurten, et al.. (2002). Astım bronşiyale olgularında serum glutatyon peroksidaz, superoksid dismutaz ve malonil dialdehid düzeyleri ve astım şiddeti ile ilişkisi. 13(4). 239–245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine G. Lam Breakdown of academic impact, for papers by Ahmet Alacacıoğlu Breakdown of academic impact, for papers by Florian Scotté Breakdown of academic impact, for papers by Chan Shen Breakdown of academic impact, for papers by John Leighton Breakdown of academic impact, for papers by Aram N. Demirjian Breakdown of academic impact, for papers by Michael O. Meyers Breakdown of academic impact, for papers by Yi‐Ching Hsieh Breakdown of academic impact, for papers by Giampaolo Ugolini Breakdown of academic impact, for papers by Sheetal Kircher
Rankless by CCL
2026